Top 15 Medical VC (Venture Capital) Funds in Portugal in May 2025
A list of 15 VC (Venture Capital) funds that invest in Medical startups based in Portugal. We rank investors based on the number of investments they made in Medical companies from Portugal. We update this investor list every month.Top 15 Medical VC (Venture Capital) Funds in Portugal in May 2025
Investor | Medical Portugal investments |
---|---|
Portugal Ventures | 8 |
Armilar Venture Partners | 5 |
Vesalius Biocapital Partners | 3 |
Caixa Capital | 3 |
TheVentureCity | 3 |
Critical Ventures | 2 |
SOSV | 2 |
Boehringer Ingelheim Venture Fund | 1 |
TheVentureCity | 1 |
Demium Capital | 1 |
Artesian VC | 1 |
ChangePartners | 1 |
Green Innovations | 1 |
Social Impact Fund | 1 |
Boule Diagnostics | 1 |
Verticals:Enterprise, SaaS, Security, Networks, AI, VR/AR, Marketplace, Blockchain, Internet of Things, New materials, Electronics, Robotics, Cleantech, Agrotech, Seatech, Therapeutics, Digital Health, Diagnostics, Innovative Accommodation, Tourist Entertainment Companies, Tour Operators, Wine, Nautical and Equestrian Tourism, Theme ParksMobile, Robotics Founded in 2012, Portugal Ventures is a venture capital firm based in Porto, Portugal. The firm is a part of the Banco Português de Fomento group. The firm seeks to invest in pre-seed, seed and series A stages
Show more
Investment focus
- Software, Information Technology, Health Care
- Seed, Funding Round, Pre-Seed
- Portugal, United States, France
Portfolio highlights
- Hoopers — Global basketball community platform connecting players, fans and enthusiasts through products, contents, experiences and NFTs.
- PluggableAI — Pluggable is the leading Meaningful Mobile Engagement solution where, through disruptive AI models and non-intrusive smartphone sensors, we maximize mobile app engagement.
- Corium Biotech — Corium Biotech is an R&D company dedicated to the bioproduction of exotic leather destined to answer the current leather market needs for performant materials that respect both the environment and animal wellbeing.
Armilar Venture Partners is Portugal's leading venture capitalist. An independent VC with a 20-year-old history, a high-performance track record and an international footprint, Armilar is a deep-tech investor in ICT, HealthTech and CleanTech.
Show more
Investment focus
- Software, Information Technology, Manufacturing
- Series A, Seed, Funding Round
- Portugal, United States, United Kingdom
Portfolio highlights
- Rows — Combine the power of a spreadsheet with built-in integrations from your business apps. Automate workflows and build tools that make work simpler.
- Veeton — Veeton is the creator of an artificial intelligence-powered platform for automated fashion imaging. The company's platform provides fashion firms with an alternative to photo sessions by generating a limitless range of high-quality on-model images using only packshot photos, instantaneously and at a fraction of the cost, allowing clients tocreate e-commerce shoots in a few clicks.
- Cintoo — Cintoo is essential for BIM to bridge the gap between your physical and virtual worlds.
Vesalius Biocapital Partners invests in companies active in human health through venture capital funds raised since 2007. They have contributed to developing 20 companies since inception.With more than € 150 million under management in two funds. Vesalius Biocapital Partners plays the role of lead investor in the large majority of its financingrounds.Their companies are based in Europe allowing easy interaction with management.They invest in all stages of development and do not shy away from relatively early-stage projects with a sound proprietary technology and corresponding IP, unique team skills and a clear competitive edge based on solid data.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series B, Series A, Series C
- Belgium, Germany, The Netherlands
Portfolio highlights
- CatalYm — Catalym develops antibodies against a placental factor which is overexpressed by various tumour types.
- Caresyntax — Caresyntax is the only enterprise-scale surgical data solution you need to make surgery smarter, safer, and more profitable.
- Inflammatix — Inflammatix develops rapid point of care diagnostic tests by reading the immune system, and resolves major clinical health challenges.
Caixa Capital is the Private Equity and Venture Capital arm of banking Group Caixa Geral de Depósitos and has a track record spanning over two decades of activity, since the industry was created in Portugal. It is a leading investor in terms of funds under management, portfolio size and diversity.Caixa Capital´s mission is to invest in fundsand companies, led by highly qualified management teams, with high growth and valuation potential, that enable our funds to achieve an attractive risk adjusted return and for society at large to benefit sustainably from our activity.Currently with more than 700 million Euros under management and a portfolio of over 80 investments, Caixa Capital is a reference in this area with special links to the respective European sector associations.
Show more
Investment focus
- Software, Information Technology, SaaS
- Seed, Series A, Funding Round
- Portugal, United States, Spain
Portfolio highlights
- HiJiffy — Increase direct bookings and upselling with HiJiffy's AI-powered communication solutions for hospitality.
- Probely — Probely is a web application and API vulnerability scanner for agile teams. Automate Security Testing by adding Probely into your SDLC and CI/CD pipelines.
- Infraspeak — Infraspeak is an Intelligent CMMS Software that brings outstanding flexibility, connectivity and intelligence to your operations.
TheVentureCity is a global early stage venture fund, investing in product-centric startups across the US, Europe and Latam. We believe in founders who expect more from their VC. Our data-driven nature allows us to see beyond borders, knowing talent has no zip code. Which is why we have international hubs in Miami, Madrid, San Francisco and SaoPaulo. We create a steady current of resources, offering a combination of bespoke data insights and guidance from experienced operators. With product-led growth at our core.With more than $160M under management, we invest from pre-seed/seed with a ticket size from $100-300k to Series A with $1-4M.
Show more
Investment focus
- Software, Artificial Intelligence, SaaS
- Seed, Pre-Seed, Series A
- United States, Spain, Brazil
Portfolio highlights
- Spike Technologies — November 30, 2022 - Spike technology, REST API end-points, and Cloud architecture are designed with data privacy and security at heart. We process billions of
- Tiny Health — Tiny Health is the first at-home gut health test for moms and babies 0-3 years. Detect any gut imbalances early on and prevent chronic conditions.
- Sidekick — Expertly-managed portfolios for the modern investor
We invest in game-changing companies with the power to transform the way the world uses technology.
Show more
Investment focus
- Medical, Computer, Genetics
- Seed, Series A
- Portugal, United States
Portfolio highlights
- hOS — hOS is an early-stage AI technology company.
- CBR Genomics — We apply our end-to-end solutions to hand genetic reports at the clinical desk. We make Genomics accessible!
- RunSafe Security — Secure embedded systems with RunSafe Security's runtime cybersecurity protection, integrating build-time defenses without affecting performance.
SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates.
HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.
Show more
Investment focus
- Biotechnology, Health Care, Software
- Seed, Convertible Note, Pre-Seed
- United States, India, United Kingdom
Portfolio highlights
- MixRift — MIXRIFT - game developers specialized in Mixed Reality
- unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
- Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
The Boehringer Ingelheim Venture Fund is the strategic venture fund of the Boehringer Ingelheim Corporation.
Show more
Investment focus
- Biotechnology, Health Care, Therapeutics
- Series A, Series B, Seed
- United States, Germany, Belgium
Portfolio highlights
- Aignostics — Aignostics is an AI-powered precision diagnostics focused on pathology to assist with drug development and clinical research. Its “explainable” AI overcomes the “black-box” limitations of conventional AI. Based on their patented technology for reverse-engineering the black box, they render diagnostic results explainable in the form of preciseheatmaps and image overlays. These heatmaps allow pathologists to quickly verify the results of the AI, which is crucial, as the pathologist is ultimately responsible for the diagnosis.The company was founded in 2018 and is headquartered in Berlin, Germany.
- Glox Therapeutics — Developing novel precision antibiotics based on protein bacteriocins, to target Gram-negative Antimicrobial Resistant (AMR) pathogens.
- Asgard Therapeutics — Asgard Therapeutics is a private biotech company exploring the application of direct cell reprogramming technologies for cancer immunotherapies. Formed as a spin-off from Lund University, the Company is pioneering a gene therapy approach based on its proprietary TrojanDC technology, designed to set in motion immune responses based on the biologicalproperties of professional antigen-presenting cells.
Our ticket size ranges from $100-500k for Pre-seed/Seed and $1-4M for Series A companies. We're in search of promising-founders with product-driven mindsets who have a passion for building. Those who've fallen in love with data. For we believe in fit---both product and with the team here. Got a great idea? Come to TheVentureCity and give it the expertise to help it grow.
Show more
Investment focus
- Software, Information Technology, Artificial Intelligence
- Seed, Pre-Seed, Series A
- United States, Spain, Brazil
Portfolio highlights
- Devengo — Light-speed transfers. Our Instant Payments API enables seamless integration to automate payouts to your customers in Europe and the UK.
- Plexigrid — We provide tailored solutions for electricity systems by using data analysis and optimization technology.
- BrandLovrs — BrandLovrs provides a one-of-a-kind model for gamifying influencer marketing campaigns Brands may use the BrandLovrs platform to collaborate with a large number of producers for scalable and gamified influencer marketing.
Demium is a talent investment company founded in Spain in 2013 with the aim of supporting the best professionals and helping them to carry out successful projects, always with an eminently digital and technological component. In November 2020, it's asset management company, Demium Capital, started operating with a first €50M fund to invest inmore than 75 early-stage startups per year (pre-seed/seed), becoming the most active venture capital fund in Spain. Startups such as Hannun, Voicemod, Swipcar, Citibox, Singularu or Landbot, among others have been created in the incubator. The company is present in five countries: Spain, Portugal, Poland, Ukraine and Czech Republic
Show more
Investment focus
- Software, Information Technology, Artificial Intelligence
- Pre-Seed, Seed, Series A
- Spain, Portugal, Poland
Portfolio highlights
- Dealcar — DEALCAR is a company that digitalizes the used car market through a SaaS platform, enabling fully digital transactions. This platform creates a network effect benefiting dealers, partners, and customers. • Dealers: Increase revenue by selling extra products and boost sales by reducing turnover time. • Partners: Distribute products at the pointof sale without marketing expenses, lowering operational costs. • Consumers: Purchase a used car easily in just three steps, enjoying a smooth, trusted process similar to renting but with the benefits of owning a car.
- KomboAI — Increase your sales conversion rate and close more deals with KomboAI Find the right leads, engage them with purpose and improve your skills every day. 7-Days Free Trial See Kombo in Action No credit card required Over 600+ sales reps are already using KomboAI during their job Join the sales revolution today Find the right
- Aino — Ai-powered platform to create, design, and publish interactive maps for your spatial data projects.
Artesian Capital Management is an alternative investments management company, which was spun out of ANZ Banking Group's capital markets business in 2004, with backing from ANZ Private Equity. Artesian's founding partners, purchased ANZ's stake in 2005. The company has subsequently been fully owned by partners and staff. Since 2004,Artesian has managed specialised funds focused on credit arbitrage and relative-value strategies across global financial markets. In 2008, while continuing to manage credit relative value investment strategies from its New York, London and Singapore offices, Artesian began to make principal investments in seed/early-stage ventures from its offices in Sydney, Melbourne and Shanghai. In 2011, Artesian launched the first of its early stage venture capital funds and now manages AUD +255m. Artesian's VC strategy is to partner with best of breed accelerators, incubators, angel groups and university programs. In 2017, Artesian launched its China VC Fund with a USD 50m cornerstone investment industry super fund Hostplus. Artesian will soon launch a Southeast Asia VC Fund.
Show more
Investment focus
- Software, Artificial Intelligence, Information Technology
- Seed, Series A, Pre-Seed
- Australia, United States, Hong Kong
Portfolio highlights
- Strong Room AI — Software that enables high-strength care through streamlined workflows, continuous analytics, surfaced insights and safeguarded data.
- Modern Synthesis — Combining biology, material science, engineering and human ingenuity, we create textiles that are circular by nature, and customisable by design.
- Fleet Space Technologies — Fleet is an agile, next generation connectivity company. Our mission is to Connect Everything using cutting-edge communications and space technologies to maximise the resource efficiency of human civilisation and enable the next industrial revolution with our free, ubiquitous connectivity platform.
ChangePartners is an independent company dedicated to mid-size transactions in the Iberian market.
They develop high value added solutions specific to each particular situation , offering a fair and unbiased opinion. Their independence guarantees no conflicts of interest. Their small size and focus ensures full dedication to each transaction.
Show more
Investment focus
- Medical, Therapeutics, Biotechnology
- Seed
- Portugal
Portfolio highlights
- Exogenus Therapeutics — Exogenus Therapeutics is engineering cell biology for innovative therapeutic solutions.Exo-T is a biotechnology company dedicated to the pre-clinical and clinical development of innovative cellular-based therapies applied to regenerative medicine, specifically for the skin lesions treatment. The company is presently developing its first product,Exo-Wound, for the treatment of chronic wounds.The project that led to the creation of the company (Nanoinspire) participated in COHiTEC 2014 program and is the result of the research developed in collaboration with Crioestaminal SA, Biocant, and Centre for Neurosciences and Cellular Biology of Coimbra University.
International, Life Sciences, Biotechnology
Show more
Investment focus
- Medical, Genetics, Health Care
- Series A
- Portugal
Portfolio highlights
- CBR Genomics — We apply our end-to-end solutions to hand genetic reports at the clinical desk. We make Genomics accessible!
SIF provides financial support for public charities & acts as a fiscal agent for charities and foundations.
Show more
Investment focus
- Apps, Video, Medical
- Seed
- Portugal, United States
Portfolio highlights
- Criam — CRIAM stands for Chemical Reaction and Image Analysis for Mobility. We are a Medtech startup born in January 2016 focused in the Point-of-Care diagnostic segment. Our mission is to provide fast, affordable and in-situ blood test analysis to empower people with instant information about their well-being and health conditions. With our device as aplatform approach we will be able to monitor, control and contain diseases worldwide.
- MemoryWell — MemoryWell is a digital platform for storytelling that brings the skills of professional writers to the challenge of helping elders tell their life story. With MemoryWell+, you can build a collaborative timeline around that story, adding photos, videos, letters and documents. Everyone has a story, let us help you capture it.
Boule develops, manufactures, and markets hematology analyzers for both human and veterinary markets. Read more about us here.
Show more
Investment focus
- Medical, Health Care, Medical Device
- Series A
- Portugal
Portfolio highlights
- Biosurfit — At biosurfit they are working to shape the future of in-vitro diagnostic testing. They want health providers to have all the necessary information to make the best possible diagnostic and treatment decision when they are with their patients
Investors by industry
Impact
Biotech
Gaming
FinTech
Google
Energy
Proptech
Marketplace
Consumer
Hardware
Artificial intelligence
Health Care
Climate
Community
EdTech
Sustainability
Venture Capital
Clean Energy
Real Estate
Financial Services
Video Games
B2B
Education
Publishing
Finance
Food and Beverage
Beauty
Infrastructure
Web3
Photography
Retail
Big Data
Organic Food
Payments
Social Media
Medical
Internet
Manufacturing
eSports
Construction
Digital Media
Art
Local
Sports
Music
Enterprise Software
Social Network
Wellness
Email
Franchise
Android
Mobile
Legal
Mobile Advertising
Platforms
Cannabis
Hospitality
Biotechnology
Travel
Fitness
Recruiting
Automotive
Medical Device
Social
Crowdfunding
Wine And Spirits
CleanTech
Transportation
Mobile Apps
InsurTech
Enterprise
LGBT
Fashion
Oil and Gas
Film
Life Science
Theatre
Non Profit
Renewable Energy
SaaS
Sporting Goods
Restaurants
Social Impact
Celebrity
Software
Cryptocurrency
Machine Learning
Agriculture (agtech)
Media (entertainment)
Facebook
Blockchain
Investors by country
United Kingdom
Germany
India
United States
Ireland
South Korea
Canada
Australia
New Zealand
Middle East
Oceania
Europe
Asia
South Africa
Armenia
Brazil
Qatar
Indonesia
Spain
China
Saudi Arabia
Sri Lanka
Vietnam
Africa
LATAM
Japan
Singapore
Finland
Estonia
Hungary
Ethiopia
Hong Kong
Georgia
Egypt
Ecuador
Denmark
France
Faroe Islands
Ghana
Croatia
Gibraltar
Bulgaria
Chile
Mali
Belize
Barbados
Costa Rica
Mexico
Liberia
Israel
Philippines
Malaysia
Italy
Lithuania
Liechtenstein
Kuwait
Norway
Morocco
Myanmar
Lebanon
Mauritius
Peru
Jersey
Panama
Malta
Nicaragua
Sweden
El Salvador
Uruguay
Portugal
Zambia
Ukraine
Uzbekistan
Senegal
Seychelles
Venezuela
Tajikistan
Taiwan
Serbia
Uganda
Sierra Leone
Turkey
Thailand
Tunisia
San Marino
Rwanda
Puerto Rico
Poland
Russian Federation
Tanzania
Slovenia
Zimbabwe
Togo
Dominican Republic
Azerbaijan
Nigeria
Bahamas
Namibia
Iceland
Iraq
United Arab Emirates
Jamaica
Honduras
Isle of Man
Bolivia
Luxembourg
Greece
Albania
Pakistan
Belgium
Bahrain
Belarus
Bermuda
Czech Republic
Algeria
Grenada
Romania
Jordan
Argentina
Bangladesh
Kazakhstan
Kenya
Cayman Islands
Cambodia
Austria
Oman
Cyprus
Latvia
Cameroon
Switzerland
Marshall Islands
Colombia
Guatemala
VC (Venture Capital) Funds in Portugal by industry
Crowdfunding
Financial Services
Cryptocurrency
Finance
Medical Device
Wellness
Biotechnology
Social Media
Internet
Manufacturing
Mobile
Music
Android
Blockchain
Local
Software
Sports
eSports
Hospitality
CleanTech
Mobile Advertising
FinTech
Enterprise
Health Care
Consumer
EdTech
Sustainability
Energy
Impact
SaaS
Proptech
Marketplace
B2B
Artificial intelligence
Community
Hardware
Gaming
Mobile Apps
Retail
Infrastructure
Fashion
Web3
Life Science
Big Data
Education
Medical
Transportation
Real Estate
Construction
Biotech
Renewable Energy
Payments
Food and Beverage
InsurTech
Enterprise Software
Beauty
Fitness
Media (entertainment)
Agriculture (agtech)
Machine Learning
Clean Energy
Platforms
Climate